Why the Edmonton region is a top destination for investment in life sciences

The Edmonton Region is a centre for medical device research & commercialization, with expertise in health and life sciences forming a core component of the region’s economy.

Why chose the Edmonton Metropolitan Region

Expertise in health and life sciences is a core component of the region’s thriving economy. The high concentration of top-notch facilities, research and development (R&D) institutions, government-backed initiatives and strong AI capabilities are attracting some of the world’s leading researchers.

The region is home to 60% of Alberta’s life science companies. This includes Gilead Sciences who employs over 400 staff for the development and manufacturing of investigational drugs, pharmaceuticals and clinical research programs.

Click Icons To Download

"immediate investment opportunities"

summary documents

Pharmaceutical R&D

Home to renowed chemical companies with world class expertise

Health AI

Home to the 3rd globally ranked university in AI

Pharmaceutical manufacturing

Home to top AI research centres


Entire value chain to support the discovery, production and export

Learn why companies like Gilead chose the Edmonton region

We are at CPhI worldwide in Milan

Come say Hi

Meet Edmonton Global representative Robert Sikora, Senior Manager, Business Development, at this year’s largest pharmaceutical exhibition. We will be pleased to discuss our current ecosystem and the various opportunities in the Edmonton Metropolitan Region. Do not hesitate to contact us to arrange a virtual, fill the contact form below

Robert Sikora, Senior Manager, Business Development

Contact Robert

Recent News

Life Sciences

U of A-industry partnership poised to close Canada’s drug supply gaps

The Canadian Critical Drug Initiative aims to transform Alberta into a powerhouse in the development of life-saving therapies. EDMONTON, AB Andrew MacIsaac, CEO of Applied …

Read More →
Life Sciences

PBG BioPharma Inc. Receives Health Canada Cannabis Processing Licence

Leduc-based biopharmaceutical company PBG BioPharma announced this week that Health Canada has issued the company a Standard Processing Licence under the Cannabis Act, allowing them …

Read More →
Life Sciences

AI innovation will make thyroid ultrasounds faster and easier

FDA approves U of A spinoff company MEDO’s tool offering simpler, more reliable diagnostic scans for thousands of patients A University of Alberta spinoff company …

Read More →
Life Sciences

Merck Canada to invest in Alberta synthetic data project

New partnership will explore the ability to use synthetic data to unlock health data utilization. Today Health City and the Institute of Health Economics (IHE) …

Read More →
Life Sciences

Roche Canada Launches National Artificial Intelligence Centre of Excellence

Roche partners with AI leaders Amii, Mila and the Vector Institute to drive digital transformation in health Hoffmann-La Roche Limited (Roche Canada) recently launched their …

Read More →
Life Sciences

Edmonton company blazes new trail in drug discovery

A University of Alberta spinoff company, 48Hour Discovery is using their technology to both de-risk and accelerate the drug discovery process.  Their technology applies the …

Read More →

Thank you for your submission!

Contact Us

Subscribe to our newsletter! 

Suite 100 - 10020 100 St.NW
T5J 0N5 Edmonton, AB.
© Edmonton Global.
All rights reserved
Edmonton Global is located and operates in Amiskwaciwâskahikan on Treaty 6 Territory. We acknowledge this land as the traditional gathering place and center for trade for many First Nations, Metis, and Inuit peoples. We recognize that inclusivity is at the heart of sustainable growth and understand that Indigenous partnerships and voices must be at the forefront of radical transformation of our region.

Fill out the information to begin your download